CYP3A Inducer
Showing 1 - 25 of 2,030
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Healthy Subjects, Drug-drug Interaction, Pharmacokinetics Trial in San Antonio (Efavirenz, Quizartinib)
Completed
- Healthy Subjects
- +3 more
-
San Antonio, TexasWorldwide Clinical Trials
Jun 3, 2022
Healthy, Male Trial in Daytona Beach (Zanubrutinib, Rifabutin)
Completed
- Healthy
- Male
-
Daytona Beach, FloridaCovance Clinical Research Unit
Aug 30, 2021
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Trial in Cypress (Part A, Part B)
Completed
- Healthy
- Part A
- Part B
-
Cypress, CaliforniaWest Coast Clinical Trials (WCCT)
Jun 16, 2021
Healthy Participants Trial in Austin (Vonoprazan, Rifampin)
Withdrawn
- Healthy Participants
-
Austin, TexasPPD Development, LP, 7551 Metro Center Drive, Suite 200
Feb 10, 2022
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)
Not yet recruiting
- Healthy Adult Subjects
-
Tempe, ArizonaCelerion, Inc.
Jun 16, 2023
Healthy Participants Trial in Minato-ku (E7090, Rabeprazole 20 mg, Rifampin 600 mg)
Completed
- Healthy Participants
- E7090
- +2 more
-
Minato-ku, Tokoyo, JapanEisai trial site #1
Oct 29, 2021
Healthy Subjects, Drug-drug Interaction, Pyrotinib Trial in Shanghai (Pyrotinib Maleate, Efavirenz)
Unknown status
- Healthy Subjects, Drug-drug Interaction, Pyrotinib
- Pyrotinib Maleate
- Efavirenz
-
Shanghai, Shanghai, ChinaJiangsu HengRui Medicine Co., Ltd.
Apr 21, 2021
COVID-19 Pneumonia Trial in Hangzhou (STI-1558, Itraconazole, Rifampin)
Not yet recruiting
- COVID-19 Pneumonia
- STI-1558
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Xiaoshan Hospital
Jan 5, 2023
Healthy Participants Trial in Madison (AMG 510, Rifampin)
Completed
- Healthy Participants
- AMG 510
- Rifampin
-
Madison, WisconsinCovance Clinical Research Unit, Inc 3402 Kinsman Boulevard
Oct 10, 2022
Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid
Completed
- Drug-Drug Interaction
- ITF2357 Givinostat 10mg/mL
- +4 more
-
Porto, PortugalHospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022
Healthy Volunteers Trial in Daytona Beach (LOXO-305, Itraconazole, Rifampin)
Completed
- Healthy Volunteers
- LOXO-305
- +2 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Nov 23, 2021
Healthy, Drug Drug Interaction Trial in Springfield (Itraconazole, Rifampin, KBP-5074)
Completed
- Healthy
- Drug Drug Interaction
- Itraconazole
- +2 more
-
Springfield, MissouriQPS Missouri
Mar 19, 2021
All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,
Active, not recruiting
- All Malignancies
- +11 more
- Tazemetostat
- +2 more
-
Encinitas, California
- +9 more
May 20, 2022